Invention Grant
- Patent Title: Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infections
-
Application No.: US15349934Application Date: 2016-11-11
-
Publication No.: US09732092B2Publication Date: 2017-08-15
- Inventor: Haolun Jin , Scott E. Lazerwith , Hyung-Jung Pyun , Elizabeth M. Bacon , Philip Anthony Morganelli , Mingzhe Ji
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: A61K31/5365
- IPC: A61K31/5365 ; C07D413/14 ; C07D498/14 ; A61K45/06 ; A61K31/537 ; A61K31/553
![Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infections](/abs-image/US/2017/08/15/US09732092B2/abs.jpg.150x150.jpg)
Abstract:
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, X, W, Y1, Y2, Z1, and Z4 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Public/Granted literature
- US20170057976A1 POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Public/Granted day:2017-03-02
Information query